Drug intelligence / Profile preview

桂龙丹颗粒

Development stage: Unknown
Lead developer: 藥捷安康
Administration: Oral

Overview

桂龙丹颗粒 (Guilongdan Granules), also known as Pink Granules, is a Traditional Chinese Medicine (TCM) formulation manufactured by GuiLong Pharmaceutical Anhui Co., Ltd. It is composed of a blend of traditional Chinese medicinal herbs, including Astragalus, Chinese angelica, red peony root, Ligusticum chuanxiong, peach kernel, safflower, fructus aurantii, platycodon, Achyranthes bidentata, Ophiopogon japonicus, and Radix Trichosanthis. This combination of herbs is traditionally used to invigorate blood, dispel blood stasis, tonify Qi and blood, regulate Qi, clear heat, and moisten dryness. It is administered orally.

Other names: Pink Granules

Targets

IL1B (Interleukin-1 beta)PIK3CA (Phosphoinositide 3-kinase alpha)EGFR T790M (Epidermal growth factor receptor T790M mutant)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on 桂龙丹颗粒.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 桂龙丹颗粒.

Explore the full profile